News

Article

Sucralfate Oral Suspension Recalled Due to Microbial Contamination

Author(s):

VistaPharm is recalling Sucralfate Oral Suspension, 1g/10mL because of Bacillus cereus contamination.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

FDA announced on Sept. 22, 2023 that VistaPharma is voluntarily recalling one lot of Sucralfate Oral Suspension, 1g/10mL, because of contamination of the product by Bacillus cereus. The product, which is used as an antiulcer therapeutic and distributed nationwide, is packaged in a 16 oz (414 mL) polyethylene terephthalate bottle with NDC 66689-305-16. The recalled lot is number 810300 with an expiration date of Oct. 31, 2023.

Microbial contamination of the oral suspension may result in life-threatening infections, such as endocarditis and necrotizing soft tissue infections, according to a press release. As of the time of the press release, the company had not received any reports of adverse events. Adverse events may be reported to FDA via the agency’s MedWatch Adverse Event Reporting program.

The recall is being undertaken by a contractor, Inman, which is notifying distributors and arranging for the return of recalled product.

Source: FDA

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More